| pubmed-article:382661 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:382661 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:382661 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:382661 | lifeskim:mentions | umls-concept:C0019151 | lld:lifeskim |
| pubmed-article:382661 | lifeskim:mentions | umls-concept:C0017687 | lld:lifeskim |
| pubmed-article:382661 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
| pubmed-article:382661 | lifeskim:mentions | umls-concept:C0002520 | lld:lifeskim |
| pubmed-article:382661 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:382661 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:382661 | pubmed:dateCreated | 1979-10-17 | lld:pubmed |
| pubmed-article:382661 | pubmed:abstractText | Increased glucagon (IRG) levels have been documented in liver cirrhosis, particularly associated with portal-systemic shunting. In spite of increased insulin (IRI) levels, IRI/IRG are reduced. This alteration has been proposed to have a pathogenic role in plasma aminoacid imbalance which seems to account for hepatic encephalopathy. We studied IRG and IRI/IRG in 13 controls and in 3 groups of cirrhotics, divided on the basis of their mental state. Glucagon was determined by means of 30 K Unger's antibody; insulin by a double antibody technique. Results are expressed in the table as means +/- SEM. (Formula: see text)A progressive increase in IRG secretion is present in cirrhotics and correlates with the mental state; IRI/IRG is not altered in cirrhosis until neurological distrubances are present. A relative fall in IRI which can no more balance the increasing IRG values characterizes hepatic encephalopathy. | lld:pubmed |
| pubmed-article:382661 | pubmed:language | eng | lld:pubmed |
| pubmed-article:382661 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:382661 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:382661 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:382661 | pubmed:issn | 0044-2771 | lld:pubmed |
| pubmed-article:382661 | pubmed:author | pubmed-author:MarchesiniGG | lld:pubmed |
| pubmed-article:382661 | pubmed:author | pubmed-author:ZoliMM | lld:pubmed |
| pubmed-article:382661 | pubmed:author | pubmed-author:ForlaniGG | lld:pubmed |
| pubmed-article:382661 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:382661 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:382661 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:382661 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:382661 | pubmed:pagination | 469-76 | lld:pubmed |
| pubmed-article:382661 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-H... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-A... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-A... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-B... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-I... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-T... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-T... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-L... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-V... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-D... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-H... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-I... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-G... | lld:pubmed |
| pubmed-article:382661 | pubmed:meshHeading | pubmed-meshheading:382661-A... | lld:pubmed |
| pubmed-article:382661 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:382661 | pubmed:articleTitle | The role of insulin and glucagon in the plasma aminoacid imbalance of chronic hepatic encephalopathy. | lld:pubmed |
| pubmed-article:382661 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:382661 | pubmed:publicationType | Review | lld:pubmed |
